Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Cameron D Thomas"'
Autor:
Larisa H. Cavallari, Craig R. Lee, Francesco Franchi, Ellen C. Keeley, Joseph S. Rossi, Cameron D. Thomas, Yan Gong, Caitrin W. McDonough, Petr Starostik, Maryam J. Al Saeed, Latonya Been, Natasha Kulick, Jean Malave, Ian R. Mulrenin, Anh B. Nguyen, Joshua N. Terrell, Grace Tillotson, Amber L. Beitelshees, Almut G. Winterstein, George A. Stouffer, Dominick J. Angiolillo
Publikováno v:
Clinical and Translational Science, Vol 17, Iss 8, Pp n/a-n/a (2024)
Abstract Dual antiplatelet therapy (DAPT) with aspirin and a P2Y12 receptor inhibitor (clopidogrel, prasugrel, or ticagrelor) is indicated after percutaneous coronary intervention (PCI) to reduce the risk of atherothrombotic events. Approximately 30%
Externí odkaz:
https://doaj.org/article/7b075fa5eb614f1a8179175d280beddf
Autor:
Kayla R. Tunehag, Cameron D. Thomas, Francesco Franchi, Joseph S. Rossi, Ellen C. Keeley, R. David Anderson, Amber L. Beitelshees, Julio D. Duarte, Yan Gong, Richard A. Kerensky, Caitrin W. McDonough, Anh B. Nguyen, Luis Ortega‐Paz, Sanjay Venkatesh, Yehua Wang, Julie A. Johnson, Almut G. Winterstein, George A. Stouffer, Dominick J. Angiolillo, Larisa H. Cavallari, Craig R. Lee
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 12 (2024)
Background Cytochrome P450 2C19 (CYP2C19) intermediate and poor metabolizer patients exhibit diminished clopidogrel clinical effectiveness after percutaneous coronary intervention (PCI). However, outcome studies to date have lacked racial diversity.
Externí odkaz:
https://doaj.org/article/50016bae702e4bcbb5b7ae35deb0f244
Autor:
Larisa H. Cavallari, Emily Cicali, Kristin Wiisanen, Roger B. Fillingim, Hrishikesh Chakraborty, Rachel A. Myers, Kathryn V. Blake, Bolanle Asiyanbola, Jordan F. Baye, Wesley H. Bronson, Kelsey J. Cook, Erica N. Elwood, Chancellor F. Gray, Yan Gong, Lindsay Hines, Joseph Kannry, Natalie Kucher, Sheryl Lynch, Khoa A. Nguyen, Aniwaa Owusu Obeng, Victoria M. Pratt, Hernan A. Prieto, Michelle Ramos, Azita Sadeghpour, Rajbir Singh, Marc Rosenman, Petr Starostik, Cameron D. Thomas, Emma Tillman, Paul R. Dexter, Carol R. Horowitz, Lori A. Orlando, Josh F. Peterson, Todd C. Skaar, Sara L. Van Driest, Simona Volpi, Deepak Voora, Hari K. Parvataneni, Julie A. Johnson, for the IGNITE Pragmatic Trials Network
Publikováno v:
Clinical and Translational Science, Vol 15, Iss 10, Pp 2479-2492 (2022)
Abstract Opioid prescribing for postoperative pain management is challenging because of inter‐patient variability in opioid response and concern about opioid addiction. Tramadol, hydrocodone, and codeine depend on the cytochrome P450 2D6 (CYP2D6) e
Externí odkaz:
https://doaj.org/article/45b2d593bd564fc0a4c8524c8e05af02
Autor:
Amber L. Beitelshees, Cameron D. Thomas, Philip E. Empey, George A. Stouffer, Dominick J. Angiolillo, Francesco Franchi, Sony Tuteja, Nita A. Limdi, James C. Lee, Julio D. Duarte, Rolf P. Kreutz, Todd C. Skaar, James C. Coons, Jay Giri, Caitrin W. McDonough, Rachel Rowland, James M. Stevenson, Thuy Thai, Mark R. Vesely, Jacob T. Wellen, Julie A. Johnson, Almut G. Winterstein, Larisa H. Cavallari, Craig R. Lee
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 4 (2022)
Background Studies have demonstrated increased risk of major atherothrombotic events in CYP2C19 loss‐of‐function (LOF) variant carriers versus non‐carriers treated with clopidogrel after percutaneous coronary intervention (PCI). We sought to ev
Externí odkaz:
https://doaj.org/article/fdde104f3e8e43f68d0603d9571a4e08
Publikováno v:
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 43:158-175
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::82491bd597ab816483251438a236d19c
https://doi.org/10.1002/phar.2758
https://doi.org/10.1002/phar.2758
Autor:
Larisa H, Cavallari, Emily, Cicali, Kristin, Wiisanen, Roger B, Fillingim, Hrishikesh, Chakraborty, Rachel A, Myers, Kathryn V, Blake, Bolanle, Asiyanbola, Jordan F, Baye, Wesley H, Bronson, Kelsey J, Cook, Erica N, Elwood, Chancellor F, Gray, Yan, Gong, Lindsay, Hines, Joseph, Kannry, Natalie, Kucher, Sheryl, Lynch, Khoa A, Nguyen, Aniwaa Owusu, Obeng, Victoria M, Pratt, Hernan A, Prieto, Michelle, Ramos, Azita, Sadeghpour, Rajbir, Singh, Marc, Rosenman, Petr, Starostik, Cameron D, Thomas, Emma, Tillman, Paul R, Dexter, Carol R, Horowitz, Lori A, Orlando, Josh F, Peterson, Todd C, Skaar, Sara L, Van Driest, Simona, Volpi, Deepak, Voora, Hari K, Parvataneni, Julie A, Johnson
Publikováno v:
Clinical and Translational Science. 15:2479-2492
Opioid prescribing for postoperative pain management is challenging because of inter-patient variability in opioid response and concern about opioid addiction. Tramadol, hydrocodone, and codeine depend on the cytochrome P450 2D6 (CYP2D6) enzyme for f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::514622cf573e7c6dcb3486903527c9c7
https://doi.org/10.1111/cts.13376
https://doi.org/10.1111/cts.13376
Implementation of CYP2C19 genotyping to guide proton pump inhibitor use at an academic health center
Autor:
Emily J Cicali, Cameron D Thomas, Amanda Elchynski, Benish Alam, Rachel Dalton, Rick Davis, Eda Eken, David Estores, Khoa Nguyen, Larisa H Cavallari, Kristin Wiisanen
Publikováno v:
American Journal of Health-System Pharmacy.
Disclaimer In an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eee380810e13f5a99688b4d8133ed130
https://doi.org/10.1093/ajhp/zxad099
https://doi.org/10.1093/ajhp/zxad099
Publikováno v:
Pharmacotherapy.
Oral P2Y
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2b0d527102457e98059d9d53eb348cd0
https://pubmed.ncbi.nlm.nih.gov/36588476
https://pubmed.ncbi.nlm.nih.gov/36588476
Autor:
Larisa H, Cavallari, Nita A, Limdi, Amber L, Beitelshees, James C, Lee, Julio D, Duarte, Francesco, Franchi, Sony, Tuteja, Jay, Giri, Philip E, Empey, Rolf P, Kreutz, Todd C, Skaar, John M, Allen, James C, Coons, Yan, Gong, Caitrin W, McDonough, James M, Stevenson, Cameron D, Thomas, Julie A, Johnson, George A, Stouffer, Dominick J, Angiolillo, And Craig R, Lee
Publikováno v:
Clinical pharmacology and therapeutics.
Black patients suffer worse outcomes after percutaneous coronary intervention (PCI) than White patients. Inequities in antiplatelet prescribing may contribute to this health disparity. We compared P2Y
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::af136825ce60fb7fd84b9c53ed338bd5
https://pubmed.ncbi.nlm.nih.gov/36306392
https://pubmed.ncbi.nlm.nih.gov/36306392
Publikováno v:
JAMA Network Open. 6:e238585
ImportanceA platelet ADP P2Y12 receptor (P2Y12) inhibitor plus aspirin is standard therapy for patients undergoing percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS). Compared with clopidogrel, prasugrel and ticagrelor are ass
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ce187cedda24943003bc31f328e6589
https://doi.org/10.1001/jamanetworkopen.2023.8585
https://doi.org/10.1001/jamanetworkopen.2023.8585